Literature DB >> 1972255

Amphotericin-resistant aspergillus osteomyelitis controlled by itraconazole.

M K Sachs, R G Paluzzi, J H Moore, H S Fraimow, D Ost.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1972255     DOI： 10.1016/0140-6736(90)91513-a

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review.

Authors:  I Stratov; T M Korman; P D R Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-07       Impact factor: 3.267

Review 2.  Fungal arthritis.

Authors:  M L Cuéllar; L H Silveira; L R Espinoza
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

Review 3.  Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Brad Moriyama; Nikolaos V Sipsas; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Roberta Prinapori; Saad J Taj-Aldeen; Barry Brause; Olivier Lortholary; Thomas J Walsh
Journal:  J Infect       Date:  2013-12-27       Impact factor: 6.072

4.  Aspergillosis of the cranial base.

Authors:  M M Carr; M D Cusimano; P J Muller; J Bilbao
Journal:  Skull Base Surg       Date:  1994

5.  Sternal osteomyelitis caused by Aspergillus fumigatus in a patient with previously treated Hodgkin's disease.

Authors:  D Allen; S Ng; K Beaton; D Taussig
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

6.  Aspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Nikolaos V Sipsas; Brad Moriyama; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Saad J Taj-Aldeen; Michael Henry; Vidmantas Petraitis; David W Denning; Olivier Lortholary; Thomas J Walsh
Journal:  Med Mycol       Date:  2017-04-01       Impact factor: 4.076
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.